UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

The New England journal of medicine, 2016-06, Vol.374 (23), p.2222-2234

2016

Volltextzugriff (PDF)

If All That You Have Is a Hammer…: Can We Phenotype Our Patients with Chronic Obstructive Pulmonary Disease?

American journal of respiratory and critical care medicine, 2022-02, Vol.205 (3), p.266-267

Chapman, Kenneth R

2022

Volltextzugriff (PDF)

Chronic Obstructive Pulmonary Disease: Is Social Injustice the Elephant in the Room?

American journal of respiratory and critical care medicine, 2021-06, Vol.203 (11), p.1331-1332

Chapman, Kenneth R.

2021

Volltextzugriff (PDF)

Bench to Bedside and Back: The Evolving Story of Alpha-1 Antitrypsin Deficiency

American journal of respiratory cell and molecular biology, 2020-10, Vol.63 (4), p.403-404

Chapman, Kenneth R.

2020

Volltextzugriff (PDF)

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial

The Lancet (British edition), 2015-07, Vol.386 (9991), p.360-368

2015

Volltextzugriff (PDF)

Minimal Clinically Important Differences in Pharmacological Trials

American journal of respiratory and critical care medicine, 2014-02, Vol.189 (3), p.250-255

2014

Volltextzugriff (PDF)

Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study

The lancet respiratory medicine, 2022-01, Vol.10 (1), p.11-25

2022

Volltextzugriff (PDF)

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma

Allergy (Copenhagen), 2019-09, Vol.74 (9), p.1716-1726

2019

Volltextzugriff (PDF)

Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial

American journal of respiratory and critical care medicine, 2017-05, Vol.195 (9), p.1189-1197

2017

Volltextzugriff (PDF)

Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial

American journal of respiratory and critical care medicine, 2018-08, Vol.198 (3), p.329-339

2018

Volltextzugriff (PDF)

α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action

The lancet respiratory medicine, 2021-04, Vol.9 (4), p.337-339

2021

Volltextzugriff (PDF)

Two-Needle Technique for Lumbar Radiofrequency Medial Branch Denervation: A Technical Note

Pain physician, 2020-09, Vol.23 (5), p.E507-E516

2020

Volltextzugriff (PDF)

Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic

Chest, 2020-12, Vol.158 (6), p.2502-2510

2020

Volltextzugriff (PDF)

Improving the Management of COPD in Women

Chest, 2017-03, Vol.151 (3), p.686-696

2017

Volltextzugriff (PDF)

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

The lancet respiratory medicine, 2016-10, Vol.4 (10), p.781-796

2016

Volltextzugriff (PDF)

Response to “the Effectiveness of Dorsal Root Ganglion Neurostimulation for the Treatment of Chronic Pelvic Pain and Chronic Neuropathic Pain of the Lower Extremity: A Comprehensive Review of the Published Data”

Pain medicine (Malden, Mass.), 2021-11, Vol.22 (11), p.2771-2772

2021

Volltextzugriff (PDF)

Trust but Verify

The journal of allergy and clinical immunology in practice (Cambridge, MA), 2021-12, Vol.9 (12), p.4288-4289

Chapman, Kenneth R.

2021

Volltextzugriff (PDF)

Undiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD Study

American journal of respiratory and critical care medicine, 2016-08, Vol.194 (3), p.285-298

2016

Volltextzugriff (PDF)

Patients' and physicians’ perspectives on the burden and management of asthma: Results from the APPaRENT 2 study

Respiratory medicine, 2022-09, Vol.201, p.106948-106948, Article 106948

2022

Volltextzugriff (PDF)

Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study

The lancet respiratory medicine, 2020-10, Vol.8 (10), p.1000-1012

2020

Volltextzugriff (PDF)

Long-term Safety and Efficacy of Indacaterol, a Long-Acting β2-Agonist, in Subjects With COPD: A Randomized, Placebo-Controlled Study

Chest, 2011-07, Vol.140 (1), p.68-75

2011

Volltextzugriff (PDF)

Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial

Bioimpacts, 2020-01, Vol.10 (4), p.209-215

2020

Volltextzugriff (PDF)

Health Services Burden of Undiagnosed and Overdiagnosed COPD

Chest, 2018-06, Vol.153 (6), p.1336-1346

2018

Volltextzugriff (PDF)

Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPD

The European respiratory journal, 2019-11, Vol.54 (5), p.1900673

2019

Volltextzugriff (PDF)

Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study

The lancet respiratory medicine, 2013-09, Vol.1 (7), p.524-533

2013

Volltextzugriff (PDF)

1 – 25 von 1.292

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.081)
Mit Volltextzugriff
(1.079)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.290)
Japanisch
(123)
Spanisch
(2)
Französisch
(1)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

If All That You Have Is a Hammer…: Can We Phenotype Our Patients with Chronic Obstructive Pulmonary Disease?

Chronic Obstructive Pulmonary Disease: Is Social Injustice the Elephant in the Room?

Bench to Bedside and Back: The Evolving Story of Alpha-1 Antitrypsin Deficiency

Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial

Minimal Clinically Important Differences in Pharmacological Trials

Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma

Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial

Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial

α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action

Two-Needle Technique for Lumbar Radiofrequency Medial Branch Denervation: A Technical Note

Addressing Reduced Laboratory-Based Pulmonary Function Testing During a Pandemic

Improving the Management of COPD in Women

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

Response to “the Effectiveness of Dorsal Root Ganglion Neurostimulation for the Treatment of Chronic Pelvic Pain and Chronic Neuropathic Pain of the Lower Extremity: A Comprehensive Review of the Published Data”

Trust but Verify

Undiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD Study

Patients' and physicians’ perspectives on the burden and management of asthma: Results from the APPaRENT 2 study

Once-daily, single-inhaler mometasone–indacaterol–glycopyrronium versus mometasone–indacaterol or twice-daily fluticasone–salmeterol in patients with inadequately controlled asthma (IRIDIUM): a randomised, double-blind, controlled phase 3 study

Long-term Safety and Efficacy of Indacaterol, a Long-Acting β2-Agonist, in Subjects With COPD: A Randomized, Placebo-Controlled Study

Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial

Health Services Burden of Undiagnosed and Overdiagnosed COPD

Efficacy and safety of inhaled α1-antitrypsin in patients with severe α1-antitrypsin deficiency and frequent exacerbations of COPD

Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study

Suchergebnisse filtern